Exact Imaging commended by Frost & Sullivan for ExactVu, its micro-ultrasound system for targeted prostate biopsies
Current Location:
> This Story

Forward Printable StoryPrint Comment




Ultrasound Homepage

Innovatus Imaging posts record growth for ultrasound probe repair services

The power of 4D technology advances care for heart patients

Comparison between major types of arthritis based on diagnostic ultrasonography

Innovatus Imaging releases exclusive rapid repair program for Philips X8-2t ultrasound probes

Ultrasound guidance improves first-attempt IV success in IV access in children

Exo Imaging emerges from stealth mode with $35M Series B financing round to advance development of the Exo ultrasound platform

What you don’t know about transducer repairs could impact patient care

Can increased “transducer time” lead to work-related musculoskeletal disorders?

AHRA and Canon Medical Systems support medical imaging innovation with the 12th annual putting patients first program

Ultrasound-assisted optical imaging to replace endoscopy in breakthrough discovery

Exact Imaging commended by Frost & Sullivan for ExactVu, its micro-ultrasound system for targeted prostate biopsies

Press releases may be edited for formatting or style
LONDON, July 16, 2019 /PRNewswire/ -- Based on its recent analysis of the global prostate cancer diagnostic imaging market, Frost & Sullivan recognises Exact Imaging with the 2019 Global Technology Innovation Award for developing the world's first 29 MHz micro-ultrasound-based system, ExactVu™. This system is revolutionizing the prostate biopsy space by delivering a 300% improvement in resolution over conventional urological ultrasound systems.

"With the ability to completely visualise the anatomical details of most prostates down to 70 microns, ExactVu™ micro-ultrasound identifies zone margins, small calcified lesions, prior biopsy needle tracks, subtle deviations in prostate margins, and most importantly, allows urologists to see suspiscious regions for "targeting" their prostate biopsies," said Durga Chandrupatla, Senior Research Analyst. "Conventional ultrasound is unable to see suspiscious regions so can just facilitate "blind" biopsies, which have a 30% false negative rate. The ExactVu™ provides resolution comparable to MRI - - but on ultrasound - - so it enables targeting of biopsies in the urologist's office, at a fraction of the cost or complexity of MRI, and in a single patient visit. The ExactVu™ solution also supports both conventional and high-resolution transducers. While conventional transducers may be used for abdominal and general urological imaging, the high-resolution transducer, operating at 29 MHz, provides the excellent spatial resolution required for detailed visualisation of the prostate to look for suspicious regions."

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

ExactVu™ also allows for abdominal imaging, including kidney, bladder, and large prostate procedures. Groups have also published on initial successes using the high-resolution micro-ultrasound as an alternative to magnetic resonance imaging (MRI) in bladder cancer. Specifically, because the micro-ultrasound accurately demarcates the normal anatomy of the bladder wall from bladder tumours, it has been shown to distinguish non-muscle invasive bladder cancer from muscle-invasive bladder cancer, with a strong pathological correlation.

In addition, Exact Imaging's platform may be a superior clinical solution for image-guided, focused laser ablation (FLA) for urology by eliminating the need for costly and time-consuming MRI guidance during the procedure, thus making the treatment faster, more accurate, and cost effective. Exact Imaging's micro-ultrasound real-time imaging and biopsy guidance solution has the potential to dramatically increases the clinician's ability to target diseased tissue and receive superior guidance during the procedure, in terms of monitoring the FLA treatment.
  Pages: 1 - 2 - 3 >>

Ultrasound Homepage

You Must Be Logged In To Post A Comment